ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

161 hedge funds and large institutions have $770M invested in Achillion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$125M
Puts
$39.3M
Net Calls
Net Calls Change

Top Buyers

1 +$36M
2 +$27.5M
3 +$12.4M
4
Goldman Sachs
Goldman Sachs
New York
+$9.47M
5
Millennium Management
Millennium Management
New York
+$9.33M

Top Sellers

1 -$158M
2 -$48.8M
3 -$25.4M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$7.78M
5
Morgan Stanley
Morgan Stanley
New York
-$7.72M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$938K
77
$916K
78
$902K
79
$883K
80
$881K
81
$798K
82
$796K
83
$780K
84
$776K
85
$744K
86
$740K
87
$722K
88
$684K
89
$660K
90
$638K
91
$631K
92
$618K
93
$607K
94
$569K
95
$562K
96
$523K
97
$519K
98
$516K
99
$513K
100
$501K